Please use this identifier to cite or link to this item:
https://repo.btu.kharkov.ua/handle/123456789/57287
Title: | Cushing’s disease in dogs: diagnosis and treatment in condition of veterinary clinic VCA Spanish River Animal Hospital |
Authors: | Sarah-Ann Elizabeth, Goffe |
metadata.dc.contributor.advisor: | Sobakar, Yu. |
metadata.dc.contributor.affiliation: | State Biotechnological University Department of internal diseases and clinical diagnosis of animals |
Keywords: | Cushing’s disease;pituitary gland;adrenal gland;dogs |
Issue Date: | 2024 |
Publisher: | Kharkiv: DBTU |
Citation: | Sarah-Ann Elizabeth Goffe. Cushing's disease in dogs: diagnosis and treatment in conditions of veterinary clinic VCA Spanish River Animal Hospital: master's qualification work: spec. 211 Veterinary medicine; of science driver Yu. Sobakar. Kharkiv: DBTU, 2024. 59 p. |
Abstract: | Hyperadrenocorticism is the excessive release of corticosteroids, particularly glucocorticoids, by the adrenal glands. It may be caused by excessive ACTH release from the pituitary gland or adrenal gland disease. Excessive use of glucocorticoids can potentially cause hyperadrenocorticism. It is commonly related with increased glucocorticoid release from the adrenal glands in both dogs and humans. The cause of high corticosteroid levels in dogs determines whether it is pituitary or adrenal dependant. Cushing's syndrome in dogs is caused by prolonged exposure to excess adrenocortical hormones. It is most commonly related with high cortisol levels. Polyuria, polydipsia, polyphagia, increased hepatomegaly, and lethargy are all common indicators. The clinical symptoms include hypertrichosis, muscular weakness, hypercoagulability, hypercalcemia, ferritinemia, and azotemia. The treatment of hyperadrenocorticism is determined by patient variables. Surgery is preferable, but has drawbacks.. Primary medical therapy reduces adrenal steroid production. Re-evaluation and monitoring are necessary. Treatment varies according to clinical symptoms and patient status. Identifying and treating underlying disorders is critical. Complications include an increased risk of infection, thrombosis, diabetes, and worsening of pre-existing conditions. |
URI: | https://repo.btu.kharkov.ua//handle/123456789/57287 |
metadata.dcterms.references: | 1. Tarrido, L. (2023). Using in-clinic cortisol testing to detect endocrine diseases in dogs. dvm360.com 2. Bruyette, D. S. (2020). Pituitary-Dependent Hyperadrenocorticism in Dogs and Cats. Clinical Small Animal Internal Medicine. [HTML] 3. Karić, E., Hodžić, A., Zahirović, A., Hrković-Porobija, A., & Orhan, H. (2021). Biochemical and haematological parameters in dogs with Cushing’s syndrome. Veterinarska stanica, 52(4), 413-419. srce.hr 4. Soler Arias, E. A., Castillo, V. A., Louiset, E., & Lefebvre, H. (2022). Cushing's syndrome caused by intra-adrenocortical adrenocorticotropic hormone in a dog. Journal of veterinary internal medicine, 36(1), 264-271. wiley.com 5. Tanaka, S., Suzuki, S., Sato, A., Teshima, T., Mori, A., Sako, T., ... & Hara, Y. (2022). Utility of a corticotropin-releasing hormone test to differentiate pituitary-dependent hyperadrenocorticism from ortisol-producing adrenal tumors in dogs. Journal of Veterinary Internal Medicine, 36(1), 29-38. wiley.com 6. MacIntyre, D. K. (2020). Adrenal Dysfunction. The Veterinary ICU Book. [HTML] 7. Raux, L. A. S. (2022). Retrospective analysis of clinical endocrine cases in dogs in selected veterinary clinics of France and Estonia. emu.ee 8. Jepson, R. E. (2020). Hypertension and adrenal gland disease. Hypertension in the Dog and Cat. [HTML] 9. Carvalho, M. A. F. (2021). Diagnosis and management of naturally occurring hypercortisolism by primary care veterinarians in western europe: current trends. utl.pt 10. García San José, P. (2022). Systemic hypertension in dogs with hyperadrenocorticism: prevalence, evolution during treatment, and influence on survival. ucm.es 11. Schofield, I., Brodbelt, D. C., Niessen, S. J. M., Church, D. B., Geddes, R. F., & O'Neill, D. G. (2022). Frequency and risk factors for naturally occurring Cushing's syndrome in dogs attending UK primary-care practices. Journal of Small Animal Practice, 63(4), 265-274. wiley.com 12. Schofield, I., Brodbelt, D. C., Niessen, S. J., Church, D. B., Geddes, R. F., Kennedy, N., & O'Neill, D. G. (2020). Development and internal validation of a prediction tool to aid the diagnosis of Cushing's syndrome in dogs attending primary-care practice. Journal of veterinary internal medicine, 34(6),2306-2318. wiley.com 13. Schofield, I., Brodbelt, D. C., Kennedy, N., Niessen, S. J., Church, D. B., Geddes, R. F., & O’Neill, D. G. (2021). Machine-learning based prediction of Cushing’s syndrome in dogs attending UK primary-care veterinary practice. Scientific reports, 11(1), 9035. nature.com 14. Pivonello, R., Ferrigno, R., De Martino, M. C., Simeoli, C., Di Paola, N., Pivonello, C., ... & Colao, A. (2020). Medical treatment of Cushing's disease: an overview of the current and recent clinical trials. Frontiers in Endocrinology, 11, 648. frontiersin.org 15. Fischer, B. L. (2022). Endocrine disease. Canine and Feline Anesthesia and Co-Existing Disease, 299-335. ethernet.edu.et 16. da Silva, C. C., Cavalcante, I., de Carvalho, G. L. C., & Pöppl, Á. G. (2021). Cognitive dysfunction severity evaluation in dogs with naturally-occurring Cushing´ s syndrome: A matched case-control study. Journal of Veterinary Behavior, 46, 74-78. [HTML] 17. Juszczak, A., Morris, D., & Grossman, A. (2021). Cushing's syndrome. Endotext [Internet]. nih.gov 18. Sanders, K., Galac, S., & Meij, B. P. (2021). Pituitary tumour types in dogs and cats. The Veterinary Journal. sciencedirect.com 19. Wright, K., van Rossum, E. F., Zan, E., Werner, N., Harris, A., Feelders, R. A., & Agrawal, N. (2023). Emerging diagnostic methods and imaging modalities in cushing’s syndrome. Frontiers in Endocrinology, 14, 1230447. frontiersin.org 20. Garcia, J. L. (2020). Polyuria and Polydipsia. Clinical Small Animal Internal Medicine. [HTML] 21. Wehner, A., Glöckner, S., Weiss, B., & Ballhausen…, D. (2021). Association between ACTH stimulation test results and clinical signs in dogs with hyperadrenocorticism treated with trilostane. The Veterinary …. sciencedirect.com 22. Asadi Iraee, M. O. H. A. M. M. A. D., Avizeh, R., Razi Jalali, M., & Pourmahdi Borujeni, M. (2023). Evaluation of epidemiological and clinical findings of canine hyperadrenocorticism in Iran. Iranian Veterinary Journal, 19(1), 5-15. ivj.ir 23. Lathan, P. (2023). Laboratory diagnosis of thyroid and adrenal disease. Veterinary Clinics: Small Animal Practice. [HTML] 24. Melián, C., Blanco, B., Ginel, P. J., & Pérez-López, L. (2022). Evaluation of the ACTH stimulation test using a low dose of a depot formulation in healthy dogs and in dogs with untreated Cushing's syndrome. Research in Veterinary Science, 152, 207-211. ulpgc.es 25. Kenny, P. J. (2023). Pituitary surgery in dogs and cats: new options for common problems.. Australian Veterinary Practitioner. [HTML] 26. Spence, S. (2020). Comparing treatment methods of canine hypoadrenocorticism. gla.ac.uk 27. Boag, A. (2023). Canine hypoadrenocorticism. BSAVA Manual of Canine and Feline Endocrinology. bsavalibrary.com 28. Schofield, I., Geddes, R., Fenn, J., & Ramsey, I. (2020). Update on the treatment options for canine hyperadrenocorticism. In Practice. [HTML] 29. Lamoureux, A., Cadoré, J. L., Hugonnard, M., Chabanne, L., & Krafft, E. (2023). Iatrogenic symptomatic hypoadrenocorticism after treatment with trilostane for hyperadrenocorticism in dogs: eight cases (2008-2019). Journal of Small Animal Practice, 64(6), 409-414. wiley.com 30. Fowlie, S. (2020). Electrolyte analysis in dogs with hypoadrenocorticism: A comparison of two in-house analysers with a reference laboratory. gla.ac.uk 31. Hemmelgarn, C. (2023). Hypoadrenocorticism in the emergency setting. dvm360.com 32. de Carvalho, M. A. F. (2021). Diagnosis and Management of Naturally Occurring Hypercortisolism by Primary Care Veterinarians in Western Europe: Current Trends. [HTML] 33. Appleman, E., Schrage, A., Lamb, K. E., & Langston, C. (2021). Evaluation of iatrogenic hypocortisolemia following trilostane therapy in 48 dogs with pituitary-dependent hyperadrenocorticism. Journal of the American Animal Hospital Association, 57(5), 217-224. [HTML] 34. Yamamoto, M., Nakao, T., Ogawa, W., & Fukuoka, H. (2021). Aggressive Cushing’s disease: molecular pathology and its therapeutic approach. Frontiers in Endocrinology, 12, 650791. frontiersin.org 35. Boghian, V. (2020). Clinical biochemistry of Cushing syndrome in dogs. 193.231.26.26 36. Nishiyama, M., Iwasaki, Y., & Makino, S. (2022). Animal Models of Cushing's Syndrome. Endocrinology. [HTML] 37. Fleseriu, M., Varlamov, E. V., Hinojosa-Amaya, J. M., Langlois, F., & Melmed, S. (2023). An individualized approach to the management of Cushing disease. Nature Reviews Endocrinology, 19(10), 581-599. [HTML] 38. Hara, Y. (2020). Transsphenoidal surgery in canines: safety, efficacy and patient selection. Veterinary Medicine: Research and Reports. tandfonline.com 39. Albani, A., & Theodoropoulou, M. (2021). Persistent Cushing’s disease after transsphenoidal surgery: challenges and solutions. Experimental and Clinical Endocrinology & Diabetes, 129(03), 208-215. [HTML] 40. Vitiello, R., Perisano, C., Covino, M., Perna, A., Bianchi, A., Oliva, M. S., ... & Maccauro, G. (2020). Euthyroid sick syndrome in hip fractures: Valuation of vitamin D and parathyroid hormone axis. Injury, 51, S13-S16. [HTML] 41. Bugbee, A., Rucinsky, R., Cazabon, S., Kvitko-White, H., Lathan, P., Nichelason, A., & Rudolph, L. (2023). 2023 AAHA Selected Endocrinopathies of Dogs and Cats Guidelines. Journal of the American Animal Hospital Association, 59(3), 113-135. aaha.org 42. Divaris, E., Kostopoulos, G., & Efstathiadou, Z. A. (2024). Current and Emerging Pharmacological Therapies for Cushing's Disease. Current Pharmaceutical Design, 30(10), 757-777. [HTML] 43. Kitzmann, S., Hartmann, K., Zablotski, Y., Rieger, A., Mueller, R., & Wehner, A. (2021). Wellbeing, quality of life, presence of concurrent diseases, and survival times in untreated and treated German Shepherd dogs with dwarfism. Plos one, 16(8), e0255678. plos.org 44. Pereira, M. T., Martin, I., Rehrauer, H., Kowalewski, M. P., Boretti, F. S., & Sieber-Ruckstuhl, N. S. (2022). Effects of ACTH-Induced Long-Term Hypercortisolism on the Transcriptome of Canine Visceral Adipose Tissue. Veterinary Sciences, 9(6). nih.gov 45. Golinelli, S., de Marco, V., Leal, R. O., Barbarossa, A., Aniballi, C., Maietti, E., ... & Fracassi, F. (2021). Comparison of methods to monitor dogs with hypercortisolism treated with trilostane. Journal of Veterinary Internal Medicine, 35(6), 2616-2627. wiley.com 46. Akhter Rasool, T. S., Ali, M. M., Sureshkumar, R., & Krishnakumar, K. (2023). Hyperadrenocorticism in Dogs: Impact on Reproduction and Diagnostic Insights from Ultrasonography. Saudi J Biomed Res, 8(8), 148-153. researchgate.net 47. Miura, K., Sunahara, H., Sakai, Y., Isshiki, S., Hasegawa, M., & Oda, M. (2022). Effective treatment with mitotane for a canine case of presumed ectopic Cushing’s syndrome-related pheochromocytoma. Open Veterinary Journal, 12(5), 762-767. ajol.info |
Appears in Collections: | 211 - "Ветеринарна медицина" (Магістри) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
2024_M_211_18_11EN_HOFFE_Sarakh-Ann_Elizabet.pdf Restricted Access | 1.29 MB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.